TLDR
- Oklo’s stock price surged 15% on Monday, raising its year-to-date increase to 21%.
- The upturn was fueled by increased government attention on nuclear power and $2.7 billion in uranium-enrichment grants from the U.S. Department of Energy.
- A House Energy subcommittee declared it will assess the present state of the U.S. nuclear industry.
- Oklo obtained several Department of Energy contracts for programs related to the fuel supply chain.
- Wall Street analysts uphold a Moderate Buy rating and a $130.10 price target, indicating 45% upside.
Oklo’s shares rose almost 15% on Monday amid a broad rally among nuclear energy firms. The microreactor developer finished the day at $89.34 per share, achieving its third straight day of advances.
The company’s performance for the year now shows a 21% gain. Other nuclear stocks, including NuScale Power Corp. and Nano Nuclear, also recorded double-digit increases during the trading session.
The rally followed an announcement from the U.S. Department of Energy regarding $2.7 billion in uranium-enrichment grants. This funding supports high-assay low-enriched uranium (HALEU), a crucial material for advanced reactors.
Access to HALEU fuel has been a major operational constraint for Oklo. The company’s Aurora Powerhouse reactors require this specific fuel type to operate.
Geopolitical developments contributed to the positive movement in energy stocks. Recent military actions by U.S. forces over the weekend heightened focus on energy security, providing a lift to associated sectors.
Congressional Review and Government Contracts
The Energy subcommittee of the House of Representatives revealed its intention to evaluate the current condition of the nuclear industry. The upcoming hearing will look into licensing, deployment, and the role of recent policies in fostering industry expansion.
This move comes after an executive order issued by President Trump last year. The order seeks to increase nuclear power capacity to address growing energy needs from artificial intelligence and U.S. manufacturing.
Oklo has been awarded multiple contracts by the Department of Energy. These agreements back the Fuel Line Pilot and Reactor Pilot programs, initiatives centered on building a domestic nuclear fuel supply chain.
The company focuses on developing compact modular reactors for commercial applications. Nonetheless, regulatory approval for its inaugural 75-megawatt Aurora Powerhouse is still awaited.
The start of commercial operations is projected for late 2027 or early 2028. The company needs to navigate regulatory requirements before it can implement its technology.
Analyst Views and Future Projections
In December, H.C. Wainwright analyst Sameer Joshi reaffirmed his Buy rating on Oklo. He emphasized the company’s three-part business approach.
This strategy involves deploying Aurora Powerhouses for power production. Oklo also plans to manufacture and sell HALEU fuel and bring radioisotopes to the commercial market.
Revenue forecasts indicate significant growth potential. Analysts project the company could generate over $21 billion in revenue by 2038 if its facilities operate at full capacity.
Robust gross margins are forecast once production ramps up. The stock has appreciated nearly 200% in the past year as investors anticipate nuclear energy powering AI data centers.
The consensus rating on Wall Street for the stock is Moderate Buy. Eight analysts advocate purchasing the stock, while five advise holding.
The average price target is $130.10 per share. This implies a potential gain of 45.62% from the current price.
Analysts note the stock is trading at elevated valuations. The business’s capital-intensive characteristics pose risks for investors.
The uranium-enrichment grants from the Department of Energy may help alleviate fuel supply limitations. Government backing could reduce bottlenecks and enhance production prospects for firms such as Oklo.